A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis

Shannon M Reilly1, Maryam Ahmadian2, Brian F Zamarron3

  • 1Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, USA.

Nature Communications
|January 13, 2015
PubMed

Insights

Amlexanox treatment for obesity increases cAMP, promoting IL-6 secretion from fat cells. This improves glucose metabolism in obese mice by affecting the liver, suggesting a new therapeutic pathway for type 2 diabetes.

Area of Science:

  • Metabolic disease research
  • Molecular mechanisms of obesity
  • Diabetes therapeutics

Background:

  • Obesity and associated insulin resistance necessitate novel therapeutic strategies.
  • IKK-ε (inhibitor of κB kinase ε) and TBK1 (TANK-binding kinase 1) were previously identified as potential targets for obesity treatment.
  • Understanding the molecular pathways linking obesity, insulin resistance, and glucose metabolism is crucial.

Purpose of the Study:

  • To investigate the acute metabolic effects of amlexanox, an inhibitor of IKK-ε and TBK1, in obese mice.
  • To elucidate the role of amlexanox in modulating cAMP levels, cytokine secretion, and hepatic gene expression.
  • To explore the potential of targeting the adipose tissue-liver axis for treating metabolic dysfunction.

Main Methods:

  • Administration of amlexanox to obese mice to inhibit IKK-ε and TBK1.
  • Measurement of cyclic adenosine monophosphate (cAMP) levels in subcutaneous adipose tissue.
  • Assessment of interleukin-6 (IL-6) synthesis and secretion from adipocytes and preadipocytes.
  • Analysis of hepatic Stat3 phosphorylation and gene expression related to gluconeogenesis.
  • Preliminary analysis of similar metabolic effects in a cohort of obese patients.

Main Results:

  • Amlexanox treatment acutely increased cAMP levels in subcutaneous adipose depots of obese mice.
  • This increase in cAMP promoted the synthesis and secretion of IL-6 from adipocytes and preadipocytes.
  • IL-6 stimulated hepatic Stat3 phosphorylation, suppressing genes involved in gluconeogenesis.
  • These molecular events led to improved glucose handling in obese mice.
  • Preliminary human data suggested a similar association in obese patients.

Conclusions:

  • Amlexanox exerts acute metabolic benefits on glucose metabolism through a subcutaneous adipose tissue-liver axis.
  • The pathway involves amlexanox-induced increase in cAMP, IL-6 secretion, and subsequent hepatic gene regulation.
  • These findings highlight a novel therapeutic avenue for type 2 diabetes and obesity-related metabolic disorders.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.4K
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
4.5K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
9.1K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
17.5K
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.2K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
5.6K